0000950170-24-033514.txt : 20240319
0000950170-24-033514.hdr.sgml : 20240319
20240319162219
ACCESSION NUMBER: 0000950170-24-033514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240316
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burgess Justin
CENTRAL INDEX KEY: 0001812025
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 24763598
MAIL ADDRESS:
STREET 1: C/O DYNAVAX TECHNOLOGIES CORPORATION
STREET 2: 2100 POWELL STREET, SUITE 1900
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
ownership.xml
4
X0508
4
2024-03-16
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001812025
Burgess Justin
C/O DYNAVAX TECHNOLOGIES
2100 POWELL STREET, SUITE 720
EMERYVILLE
CA
94608
false
true
false
false
VP Finance & CAO
false
Stock Options (Right to Buy)
11.7
2024-03-16
4
A
false
20000
0
A
2031-03-16
Common Stock
20000
20000
D
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of March 16, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
/s/ JUSTIN BURGESS
2024-03-19